Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Derek Jonker, MD
Ottawa Hospital and Research Institute
Principal Investigator - James Burke, MD
Jennerex Biotherapeutics
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Juravinski Cancer Centre
Hamilton, Ontario, Canada
- Ottawa Hospital and Research Institute (ohri)
Ottawa, Ontario, Canada
- Hôpital Saint Antoine
Paris, France
- Hôpital Hautepierre
Strasbourg, France
- Institut Claudius Regaud
Toulouse, France
- Mayo Clinic
Scottsdale, Arizona, United States
- Ucsd Moores Cancer Center
La Jolla, California, United States
- Billings Clinic Cancer Center
Billings, Montana, United States
- University of North Carolina
Chapel Hill, North Carolina, United States
- Gabrail Cancer Center
Canton, Ohio, United States
- the Ohio State University
Columbus, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2012
- Primary completion
- 30 Jun 2015
- Completion
- 31 Oct 2015
- Last update posted
- 8 Jan 2021
- Registered enrollment
- 52
- Registry id
- NCT01394939
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.